Personalized medicine for the brain. A discussion with Brain Resource's Evian Gordon

PharmaResearch
Written By

The Brain Resource Company (BRC) is a global leader in personalized medicine for the brain. In this podcast interview, BRC's Executive Chairman Evian Gordon and I discuss:

  • The similarities and differences between personalized medicine for the brain and overall
  • The iSPOT study that focuses on biomarkers for depression and ADHD
  • The importance of a standardized platform
  • The business case for personalized medicine for the brain in pharmaceutical discovery and development
  • How the next few years will unfold from a brain research standpoint

If you want to hear more from Evian, you can check out a video of his recent conference presentation at Stanford.

Previous

Small businesses and the Affordable Care Act. What do they need to know?
Next

Nursing shortage. Is it a case of crying "wolf?"